Clinical Role - Specialty Pharmacy

Skidki-na-vse® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.

FDA Approves New Treatment for Erythropoietic Protoporphyria
Erythropoietic protoporphyria is a rare metabolic disorder where exposure to light may be extremely painful for affected individuals.
 
FDA OKs Wilate for Hemophilia A in Adults, Adolescents
Wilate, a von Willebrand factor replacement therapy, was approved for use in patients with hemophilia A for routine prophylaxis and on demand treatment and control of bleeding episodes.
 
Dosing Drug-Food, Drug-Drug Interactions in Common Cancer Agents
Certain cancer agents may have drug-food or drug-drug interactions that alter exposure to the medication, resulting in a need for individualized dosing.
 
Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty Pharmacy
The National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.
Trending News Today: California Pharmacists Can Now Dispense PrEP Without Prescriptions
Top news of the day from across the health care landscape.
 
Cancer Drug Costs May Not Be Factored Into Reimbursement
Study finds health-related quality of life is often not collected for novel cancer drugs when they are submitted for reimbursement.
FDA Approves PF708, a Biosimilar to Forteo, for Osteoporosis
The new drug application for PF708 was submitted under the 505(b)(2) regulatory pathway with teriparatide injection as the reference drug.
Skidki-na-vse Continuing Education™ Announces Keynote Speakers for Directions in Oncology Pharmacy™ Fall Conference Series
The keynote, Priming Pharmacists for Making an Impact in Oncology Value-Based Care, sets the stage for the entire conference and highlights how pharmacists are critical to the multidisciplinary team in providing value in patient-centered oncology care.
Prescription Drug Price Relief Act of 2019
Ron Lanton III, Esq., discusses the Prescription Drug Price Relief Act of 2019 at the National Association of Specialty Pharmacists Annual Meeting at Washington, DC.
Trending News Today: Head, Neck Melanoma Increasing Among Youth
Top news of the day from across the health care landscape. 
 
Study: Number of Drug
A new study by Prime Therapeutics LLC has shown a sharp increase in the number of drug "super spenders," defined by the researchers as members with pharmacy and medical drug therapy claims of $250,000 or more annually.
Ixekizumab Demonstrates Superiority Over Guselkumab for Moderate to Severe Plaque Psoriasis
Ixekizumab showed superiority versus guselkumab in the treatment of moderate to severe plaque psoriasis.
 
+ Load More